InvestorsHub Logo
Followers 57
Posts 5700
Boards Moderated 0
Alias Born 12/13/2004

Re: runcaly post# 12277

Monday, 12/20/2021 11:01:28 AM

Monday, December 20, 2021 11:01:28 AM

Post# of 14947
I am one of many Sorrento investors who got into the stock because of its cancer treatment and cancer pain programs. I am glad to see this oncolytic virus program progress. Abivertinib is very close to approval and there are about a dozen ADNAB(Mayo Clinic) drugs and another dozen DAR-T drugs that have great promise!

SEMDEXA and RTX are progressing well in the pain portfolio...The Scilex IPO will produce more revenue on top of the recent deal with Vickers Vantage.

The Covid portfolio will soon have a great deal of news. COVISTIX revenue is increasing and there will soon be COVI-AMG, COVIDROPS and COVI-MSC results. And I look forward to more Covid antiviral news in Q1.

Exciting times...2022 is the pivotal year for Sorrento IMO!

"The refusal of the real is the number one dogma of our time" Rene Girard

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SRNE News